Significant peaks were found at known binding sites (ESRP2 and CDH1 gene loci) in the basal‐type breast cancer cells (Horiguchi et al., 2012), but not at the HBB gene locus, which served as a negative control (Fig. 1A and data not shown). This evidence concerns the gene ESRP2 and breast carcinoma.